1,916 Followers on Owler
OverviewCompetitorsAcquisitionsInvestmentsNews & Insights

Shire Acquisitions

Shire has acquired 10 companies and its latest acquisition was Sanaplasma AG on Sep 2018

Unlock 7 more acquisitions →
COMPANY ACQUIRED
ACQUISITION DATE
AMOUNT
DESCRIPTION
Sanaplasma AG

Sep 2018

Source »
undisclosed
Sanaplasma is a biopharmaceutical company that specializes in collecting blood plasma used for the development of immunoglobulin therapies.
Baxalta Inc

Jan 2016

Source »
$32B
Baxalta is developing, manufacturing and commercializing therapies for orphan diseases.
Dyax Corp

Nov 2015

Source »
$5.9B
Dyax discovers, develops and commercializes treatments for hereditary angioedema and other rare diseases.
Foresight Biotherapeutics, Inc.

Aug 2015

Source »
$300M
Foresight Biotherapeutics is a drug development firm that develops therapies for ophthalmology and otolaryngology.
Meritage Pharma, Inc.

Feb 2015

Source »
$70M
Meritage Pharma develops and supplies prescription products for the treatment of gastrointestinal and atopic diseases.

Frequently Asked Questions about Shire

  1. What companies did Shire acquire?

    Companies acquired by Shire include Sanaplasma, Baxalta and Dyax

  2. How many acquisitions does Shire have?

    Shire has acquired 10 companies including Sanaplasma, Baxalta and Dyax.

  1. How many acquisitions did Shire make in 2018?

    In 2018 Shire acquired 1 companies including Sanaplasma.